Loading
A Mumbai company that developed the HrC test, an OCT-4A blood score it says detects and stages cancer.
Epigeneres Biotech Pvt Ltd, of Lower Parel, Mumbai, according to its authors' affiliations, developed the HrC test, which scores OCT-4A expression in peripheral blood, and an All Organ Biopsy test; its published support is company-authored.
A Mumbai company's blood test that scores one embryonic gene and claims to detect and stage any cancer; the published support is the company's own description and case studies, without accuracy figures.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/